Objective: Rhododendron Molle G. Don (rhododendron) was found to be effective on the treatment of rheumatoid arthritis and chronic glomerulonephritis. The aim of this study is to explore the role of Rhododendron on renal interstitial fibrosis (RIF) and the potential mechanism. Methods: Unilateral ureteral obstruction (UUO) was performed as RIF model. Mice were randomly divided into 6 groups (n Z 8): sham-operation group (Sham), UUO group, UUO mice treated with low dose or high dose of rhododendron root (U+r, U+R), UUO mice treated with low dose or high dose of rhododendron leaf (U+l, U+L). All mice were executed after 7 days of operation, and renal tissues were collected for pathological examination. Tubulointerstitial damage index (TDI) was measured by Masson's trichrome staining. The expression of TGF-b1, fibronectin (FN) and a-SMA in renal interstitial was analyzed by immunohistochemical method. Results: TDI was obviously increased in UUO mice, which indicated UUO model was successful. The expression of TGF-b1, FN and a-SMA in interstitial was also increased in UUO mice. However, more severe interstitial damage and higher level of TGF-b1, FN and a-SMA was found in UUO mice treated with rhododendron root, whatever high dose or low dose. The results showed that rhododendron root was harmful for renal interstitial, and TGF-b1 signaling involved in this process. But there was no difference in TDI and fibrotic indexes in UUO mice, those were treated with or without rhododendron leaf. Conclusion: Rhododendron root was reported to be useful to treat inflammatory injury mediated by immune complex. However, in this study we found rhododendron root might aggravate interstitial fibrosis in UUO model, and the side effect of rhododendron root on interstitial damage should be paid attention. The ingredients of rhododendron are complex and not entirely clear, so more examination and evidence should be analyzed before rhododendron is used in clinic. Objective: Renal interstitial fibrosis (RIF) is a common pathological process of CKD. Unfortunately, there is no satisfactory therapy to reverse this process. Recently, increasing evidences show that pericytes are the major sources of myofibroblast during RIF. Pericyte transition involved in multiple signaling pathway cross-talk, such as PDGF pathway, TGFb pathway, and VEGF pathway, and vital protein of these pathways are posttranslational modified by Fucosyltransferase 8 (Fut8). So we considered that Fut8 may play an important role in this process.
Methods: Mice kidneys were diced, incubated at 37 C for 45 minutes with liberase and Dnase in Hank's balanced salt solution. After centrifugation, cells were resuspended, and filtered by screen mesh. Then we used 42% percoll working solution to remove glomerulus and cell debris. Cells were marked by PDGFRb-PE, and isolated by FACS. Then cells were identified by immunofluorescence staining of E-cadherin, CD31, a-SMA, PDGFRb and CD73. Passage 2 to passage 5 pericytes were used in experiments, and pericytes were stimulated by TGFb1 for 24 h, 48 h for further observation. Mice UUO model was applied for in vivo observation. Results: Comparing with or without percoll in pericytes isolation, we found former can obtain a higher sorting positive percentage. Cell identification showed that E-cadherin-, CD31-, a-SMA-, PDGFRb+ and CD73+. After addition of TGFb1, increasing expressions of a-SMA, Fut8, LCA of pericytes were observed. But expression of a-SMA, Fut8, LCA were grearly reduced under TGFb1 stimulation after knockdown of Fut8 by transiently transfected Fut8-siRNA. We also found increasing co-localized expression of Fut8, LCA, PDGFRb, a-SMA in UUO model. Conclusion: Fut8 plays a vital role in process of pericyte transition, and block its function of glycosylated modification can alleviate pericyte transition. But the underlying mechanism of this phenomenon need further elaborate. Prospectively, it may hint a novel therapeutic target of RIF.
http://dx.doi.org/10.1016/j.hkjn.2015.09.110
